NIT
RARX

NumerixS Investment Technologies’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

NumerixS Investment Technologies’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$24K – 1317
2019
Q3 		$24K Buy
+1,000
New +$29.6K 0.01% 869
2019
Q2 		– Sell
-13,602
Closed -$304K – 1460
2019
Q1 		$304K Buy
+13,602
New +$292K 0.04% 531

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NumerixS Investment Technologies's RARX Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 1,000 shares — an estimated $24K sold.

NumerixS Investment Technologies first reported a position in RARX in Q1 2019 and held it in 2 quarters. The position peaked at $304K in Q1 2019. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

  • NumerixS Investment Technologies reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,000 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $24K.
  • NumerixS Investment Technologies first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • NumerixS Investment Technologies's Ra Pharmaceuticals, Inc. Common Stock position peaked at $304K in Q1 2019.
  • 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.